Precigen Inc (PGEN) support and resistance · rev $78.2M
Precigen Inc (PGEN) is a biotechnology company listed on US.
This page maps Precigen Inc (PGEN) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported PGEN revenue for 2026-06-30 was $78.2M. Net income was $12.1M. PGEN currently screens at market cap $419.2M.
PGEN currently screens at market cap $419.2M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new PGEN 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the PGEN quote page for the session range and the stock page for the full model.
Not investment advice.